Home › NDC Lookup › RxCUI directory › RxCUI 1797849

Azelastine hydrochloride 0.137 MG/ACTUAT / fluticasone propionate 0.05 MG/ACTUAT Metered D... — RxCUI 1797849

RxNorm drug concept · Semantic branded drug
RxCUI 1797849 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1797849
Official nameAzelastine hydrochloride 0.137 MG/ACTUAT / fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Dymista]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDymista (azelastine hydrochloride 137 MCG/ACTUAT / fluticasone propionate 50 MCG/ACTUAT) Metered Dose Nasal Spray; Dymista 137/50 MCG/ACTUAT Metered Dose Nasal Spray
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)26,596 prescriptions · 14 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluticasone Oral Inhalation: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No — fluticasone is a preventive inhaler, not a rescue inhaler. It works by slowly reducing airway inflammation over days to weeks, so it won't open your airways fast enough during...
  • Can I use my fluticasone inhaler when I'm having an asthma attack?
  • Great question — this is one of the most practical things you can do. When you inhale fluticasone, some of the medication can land in your mouth and throat rather than making it al...
  • Why do I need to rinse my mouth after using it?
📖 Read our full Fluticasone Oral Inhalation guide →

🕸️ Concept Web — How Azelastine hydrochloride 0.137 MG/ACTUAT / fluti... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Azelastine hydrochloride 0.137 MG/ACTUAT / fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Dymista] RxCUI 1797849

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Azelastine 18603
    • Fluticasone 41126
    • Azelastine / fluticasone 1291859
    • Azelastine hydrochloride 235824
    • Fluticasone propionate 50121
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Dymista 1291861
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Azelastine / fluticasone Metered Dose Nasal Spray 1797846
    • Azelastine hydrochloride / fluticasone propionate Metered Dose Nasal Spray 2647287
    • Azelastine / fluticasone Inhalant Product 1291856
    • Azelastine / fluticasone Nasal Product 1801231
    • Azelastine hydrochloride / fluticasone propionate Inhalant Product 2660834
    • Azelastine hydrochloride / fluticasone propionate Nasal Product 2663387
    • Azelastine / fluticasone Metered Dose Nasal Spray [Dymista] 1797848
    • Azelastine hydrochloride / fluticasone propionate Metered Dose Nasal Spray [Dymista] 2658962
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Azelastine hydrochloride 0.137 MG/ACTUAT / fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray SCD · 1797847
  • Azelastine hydrochloride 0.137 MG/ACTUAT SCDC · 860795
  • Fluticasone propionate 0.05 MG/ACTUAT SCDC · 896014
  • Azelastine / fluticasone Metered Dose Nasal Spray SCDF · 1797846
  • Azelastine hydrochloride / fluticasone propionate Metered Dose Nasal Spray SCDFP · 2647287
  • Azelastine / fluticasone Inhalant Product SCDG · 1291856
  • Azelastine / fluticasone Nasal Product SCDG · 1801231
  • Azelastine hydrochloride / fluticasone propionate Inhalant Product SCDGP · 2660834
  • Azelastine hydrochloride / fluticasone propionate Nasal Product SCDGP · 2663387

Brand-Name Concepts

  • Azelastine hydrochloride 0.137 MG/ACTUAT / fluticasone propionate 0.05 MG/ACTUAT [Dymista] SBDC · 1291862
  • Azelastine / fluticasone Metered Dose Nasal Spray [Dymista] SBDF · 1797848
  • Azelastine hydrochloride / fluticasone propionate Metered Dose Nasal Spray [Dymista] SBDFP · 2658962
  • Dymista Inhalant Product SBDG · 1291864
  • Dymista Nasal Product SBDG · 1801252
  • Dymista BN · 1291861

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1797849 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00037-0245-23 1 BOTTLE, SPRAY in 1 BOX (0037-0245-23) / 120 SPRAY, METERE... DYMISTA Viatris Specialty LLC 2016-10-01
Observed labelers: Viatris Specialty LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$9.1447
Range $9.1447–$9.1447 · middle 50% $9.1447–$9.1447 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.